Wall Street Analysts See a 258.38% Upside in Vir Biotechnology (VIR): Can the Stock Really Move This High?

Core Viewpoint - Vir Biotechnology, Inc. (VIR) shows significant upside potential with a mean price target of $31, indicating a 258.4% increase from the current trading price of $8.65 [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $32.37, suggesting variability in analyst predictions [2] - The lowest price target of $13 indicates a 50.3% increase, while the highest target of $110 suggests a potential surge of 1171.7% [2] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction [7] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about VIR's earnings prospects, with a positive trend in earnings estimate revisions [9] - Over the last 30 days, two estimates have been revised higher, leading to a 4% increase in the Zacks Consensus Estimate [10] - VIR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [11]